664 related articles for article (PubMed ID: 15155140)
21. Regulation of NuA4 histone acetyltransferase activity in transcription and DNA repair by phosphorylation of histone H4.
Utley RT; Lacoste N; Jobin-Robitaille O; Allard S; Côté J
Mol Cell Biol; 2005 Sep; 25(18):8179-90. PubMed ID: 16135807
[TBL] [Abstract][Full Text] [Related]
22. Epigenetic alterations and cancer: new targets for therapy.
Allen A
IDrugs; 2007 Oct; 10(10):709-12. PubMed ID: 17899489
[TBL] [Abstract][Full Text] [Related]
23. Chemistry of acetyl transfer by histone modifying enzymes: structure, mechanism and implications for effector design.
Hodawadekar SC; Marmorstein R
Oncogene; 2007 Aug; 26(37):5528-40. PubMed ID: 17694092
[TBL] [Abstract][Full Text] [Related]
24. DNA methylation and histone modifications in patients with cancer: potential prognostic and therapeutic targets.
Herranz M; Esteller M
Methods Mol Biol; 2007; 361():25-62. PubMed ID: 17172706
[TBL] [Abstract][Full Text] [Related]
25. Control of cardiac growth by histone acetylation/deacetylation.
Backs J; Olson EN
Circ Res; 2006 Jan; 98(1):15-24. PubMed ID: 16397154
[TBL] [Abstract][Full Text] [Related]
26. Histone deacetylase inhibitors--a new tool to treat cancer.
Somech R; Izraeli S; J Simon A
Cancer Treat Rev; 2004 Aug; 30(5):461-72. PubMed ID: 15245778
[TBL] [Abstract][Full Text] [Related]
27. Epigenetic mechanisms in AML - a target for therapy.
Oki Y; Issa JP
Cancer Treat Res; 2010; 145():19-40. PubMed ID: 20306243
[TBL] [Abstract][Full Text] [Related]
28. HATs and HDACs: from structure, function and regulation to novel strategies for therapy and prevention.
Yang XJ; Seto E
Oncogene; 2007 Aug; 26(37):5310-8. PubMed ID: 17694074
[TBL] [Abstract][Full Text] [Related]
29. Multiple functions of dynamic histone acetylation.
Davie JR; Hendzel MJ
J Cell Biochem; 1994 May; 55(1):98-105. PubMed ID: 8083305
[TBL] [Abstract][Full Text] [Related]
30. Histone modification in the TGFbetaRII gene promoter and its significance for responsiveness to HDAC inhibitor in lung cancer cell lines.
Osada H; Tatematsu Y; Sugito N; Horio Y; Takahashi T
Mol Carcinog; 2005 Dec; 44(4):233-41. PubMed ID: 16163707
[TBL] [Abstract][Full Text] [Related]
31. Abnormal histone acetylase and deacetylase expression and function in lung inflammation.
Adcock IM; Lee KY
Inflamm Res; 2006 Aug; 55(8):311-21. PubMed ID: 16977378
[TBL] [Abstract][Full Text] [Related]
32. Histone-deacetylase inhibitors: novel drugs for the treatment of cancer.
Johnstone RW
Nat Rev Drug Discov; 2002 Apr; 1(4):287-99. PubMed ID: 12120280
[TBL] [Abstract][Full Text] [Related]
33. Human papillomavirus type 16 E7 protein increases acetylation of histone H3 in human foreskin keratinocytes.
Zhang B; Laribee RN; Klemsz MJ; Roman A
Virology; 2004 Nov; 329(1):189-98. PubMed ID: 15476886
[TBL] [Abstract][Full Text] [Related]
34. Drug insight: Histone deacetylase inhibitors--development of the new targeted anticancer agent suberoylanilide hydroxamic acid.
Kelly WK; Marks PA
Nat Clin Pract Oncol; 2005 Mar; 2(3):150-7. PubMed ID: 16264908
[TBL] [Abstract][Full Text] [Related]
35. Epigenetics and the estrogen receptor.
Leader JE; Wang C; Popov VM; Fu M; Pestell RG
Ann N Y Acad Sci; 2006 Nov; 1089():73-87. PubMed ID: 17261756
[TBL] [Abstract][Full Text] [Related]
36. How does the histone code work?
Cosgrove MS; Wolberger C
Biochem Cell Biol; 2005 Aug; 83(4):468-76. PubMed ID: 16094450
[TBL] [Abstract][Full Text] [Related]
37. Chromatin remodeling, histone modifications, and DNA methylation-how does it all fit together?
Geiman TM; Robertson KD
J Cell Biochem; 2002; 87(2):117-25. PubMed ID: 12244565
[TBL] [Abstract][Full Text] [Related]
38. Protein deacetylases: enzymes with functional diversity as novel therapeutic targets.
Yoshida M; Shimazu T; Matsuyama A
Prog Cell Cycle Res; 2003; 5():269-78. PubMed ID: 14593721
[TBL] [Abstract][Full Text] [Related]
39. Role of histone acetylation in the control of gene expression.
Verdone L; Caserta M; Di Mauro E
Biochem Cell Biol; 2005 Jun; 83(3):344-53. PubMed ID: 15959560
[TBL] [Abstract][Full Text] [Related]
40. Development of histone deacetylase inhibitors for cancer treatment.
Marchion D; Münster P
Expert Rev Anticancer Ther; 2007 Apr; 7(4):583-98. PubMed ID: 17428177
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
